BIOBANKHEALING
- Biotech or pharma, therapeutic R&D
- Medical device or technology
- Other R&D services
- Synthesis, analytic, diagnostic services
BioBankHealing, established in 2016 and headquartered in Seongnam-si, South Korea, is Asia's first and Korea's largest stool bank.The company specializes in microbiome therapeutics, focusing on fecal microbiota transplantation (FMT) to treat various conditions, including Clostridioides difficile infection (CDI), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), Parkinson's disease, and colorectal cancer.Their pipeline includes multistrain microbiome-based live biotherapeutic products targeting CDI, IBS, and IBD.BioBankHealing aims to advance treatments for digestive, immune, endocrine, and neurological disorders through innovative microbiome solutions.